Drug Database
Back to search

Germany· DE-A57-5a88a7490fcb2abb

Tiaprid Stada

A tiapride product containing tiapride, registered in Germany by Stadapharm Gmbh. The same ATC class is registered in 7 of our 19 countries.

ATC N05AL03

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedTiaprid StadaATCN05AL03REGISTER NO.DE-A57-5a88a7490fcb2a…PACKS LISTED0CHECKEDSeptember 30, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tiaprideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tiapride is registered in 7 of 19 countries.

Countries holding a registration under ATC N05AL03 (tiapride), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 6 of them publish a price we can compare per daily dose
Search tiapride products by name

Tiapride · ATC N05AL03

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Italyprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tiapride costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tiapride · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Tiapride
Manufacturer
Stadapharm Gmbh
Country
Germany (DE)
ATC code
N05AL03
ATC class
Tiapride
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for tiapride.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tiapride against other medicinesHow interaction checks work

Tiapride · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Tiapride in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tiapride products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Austria · Delpral, Tiaprid G.L.
  • Belgium · Tiapridal
  • Bulgaria · Тиаприд G.L.
  • Czechia · Tiapra, Tiapralan
  • Spain · Tiaprizal
  • France · Tiapridal, Tiapride Sandoz
  • Hungary · Tiager, Tiapridal
  • Italy · Italprid, Sereprile
  • Lithuania · Hipokin, Tiapridal
  • Luxembourg · Tiapridal
  • Poland · Tiaprid Pmcs, Tiapridal
  • Portugal · Tiaprida Generis, Tiapridal
  • Romania · Tiapridal
  • Slovakia · Tiaprid Fmk, Tiaprid Pmcs

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b25efa4f-d5ba-40f9-b6fa-9c2f6a9bc15e
GET /v1/drugs/b25efa4f-d5ba-40f9-b6fa-9c2f6a9bc15e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Tiapride",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about tiapride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console